Literature DB >> 1846663

Activation of phosphatidylinositol 3-kinase in cells expressing abl oncogene variants.

L Varticovski1, G Q Daley, P Jackson, D Baltimore, L C Cantley.   

Abstract

A phosphoinositide kinase specific for the D-3 position of the inositol ring, phosphatidylinositol (PI) 3-kinase, associates with activated receptors for platelet-derived growth factor, insulin, and colony-stimulating factor 1, with products of the oncogenes src, fms, yes, crk, and with polyomavirus middle T antigen. Efficient fibroblast transformation by proteins of the abl and src oncogene families requires activation of their protein-tyrosine kinase activity and membrane association via an amino-terminal myristoylation. We have demonstrated that the PI 3-kinase directly associates with autophosphorylated, activated protein-tyrosine kinase variants of the abl protein. In vivo, this association leads to accumulation of the highly phosphorylated products of PI 3-kinase, PI-3,4-bisphosphate and PI-3,4,5-trisphosphate, only in myristoylated, transforming abl protein variants. Myristoylation thus appears to be required to recruit PI 3-kinase activity to the plasma membrane for in vivo activation and correlates with the mitogenicity of the abl protein variants.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846663      PMCID: PMC359788          DOI: 10.1128/mcb.11.2.1107-1113.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  41 in total

1.  The viral tyrosine protein kinases.

Authors:  B M Sefton
Journal:  Curr Top Microbiol Immunol       Date:  1986       Impact factor: 4.291

Review 2.  Protein-tyrosine kinases.

Authors:  T Hunter; J A Cooper
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

3.  Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity.

Authors:  D R Kaplan; M Whitman; B Schaffhausen; D C Pallas; M White; L Cantley; T M Roberts
Journal:  Cell       Date:  1987-09-25       Impact factor: 41.582

4.  The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization.

Authors:  R A Van Etten; P Jackson; D Baltimore
Journal:  Cell       Date:  1989-08-25       Impact factor: 41.582

5.  Role of tyrosine kinase and membrane-spanning domains in signal transduction by the platelet-derived growth factor receptor.

Authors:  J A Escobedo; P J Barr; L T Williams
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

6.  Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity.

Authors:  D K Morrison; D R Kaplan; U Rapp; T M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Purification and characterization of phosphoinositide 3-kinase from rat liver.

Authors:  C L Carpenter; B C Duckworth; K R Auger; B Cohen; B S Schaffhausen; L C Cantley
Journal:  J Biol Chem       Date:  1990-11-15       Impact factor: 5.157

8.  Phosphatidylinositol kinase activity associates with viral p60src protein.

Authors:  Y Fukui; H Hanafusa
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

9.  The colony stimulating factor-1 receptor associates with and activates phosphatidylinositol-3 kinase.

Authors:  L Varticovski; B Druker; D Morrison; L Cantley; T Roberts
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

10.  Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation.

Authors:  M P Kamps; J E Buss; B M Sefton
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

View more
  50 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  Purification and characterization of a phosphatidylinositol 3-kinase complex from bovine brain by using phosphopeptide affinity columns.

Authors:  M J Fry; G Panayotou; R Dhand; F Ruiz-Larrea; I Gout; O Nguyen; S A Courtneidge; M D Waterfield
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

3.  Functional asymmetry of the regions juxtaposed to the membrane-binding sequence of polyomavirus middle T antigen.

Authors:  J Dahl; U Thathamangalam; R Freund; T L Benjamin
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

4.  Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.

Authors:  T Skorski; A Bellacosa; M Nieborowska-Skorska; M Majewski; R Martinez; J K Choi; R Trotta; P Wlodarski; D Perrotti; T O Chan; M A Wasik; P N Tsichlis; B Calabretta
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

5.  Tyrosine mutations within the alpha platelet-derived growth factor receptor kinase insert domain abrogate receptor-associated phosphatidylinositol-3 kinase activity without affecting mitogenic or chemotactic signal transduction.

Authors:  J C Yu; M A Heidaran; J H Pierce; J S Gutkind; D Lombardi; M Ruggiero; S A Aaronson
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

6.  Depletion of Pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoforms.

Authors:  Isao Hirano; Satoki Nakamura; Daisuke Yokota; Takaaki Ono; Kazuyuki Shigeno; Shinya Fujisawa; Kaori Shinjo; Kazunori Ohnishi
Journal:  J Biol Chem       Date:  2009-03-04       Impact factor: 5.157

7.  Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells.

Authors:  C Huang; W Y Ma; Z Dong
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

8.  The v-Src SH3 domain binds phosphatidylinositol 3'-kinase.

Authors:  X Liu; L E Marengere; C A Koch; T Pawson
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

Review 9.  FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis.

Authors:  Zainab Jagani; Amrik Singh; Roya Khosravi-Far
Journal:  Biochim Biophys Acta       Date:  2007-10-16

10.  Nonmyristoylated Abl proteins transform a factor-dependent hematopoietic cell line.

Authors:  G Q Daley; R A Van Etten; P K Jackson; A Bernards; D Baltimore
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.